Navigation Links
Biopure Announces 2008 Third Quarter Financial Results
Date:8/21/2008

iod in 2007. Insurance premiums, travel expenses and audit fees decreased during the third fiscal quarter of 2008 compared to the same period in 2007. Compensation expense, including salaries and equity compensation, decreased during the third fiscal quarter of 2008 compared to the same period in 2007 but were offset by a one-time severance charge of $249,000 related to the reduction in force.

Financial Condition

At July 31, 2008, Biopure had $1.7 million in cash on hand. During the third fiscal quarter the Company signed an agreement with purchasers for a private placement of its common stock and warrants. Under this agreement, the Company had raised $800,000 as of July 31, 2008, raised $400,000 in August and expects to raise an additional $1.1 million over the next three months, subject to certain conditions, including a requirement that the Company raise additional funds before September 30, 2008.

Recent Developments

Clinical

Both Biopure and the Naval Medical Research Center (NMRC) continue to be in discussions with the Food and Drug Administration (FDA) for proposed clinical trials. The trial in discussion between Biopure and the FDA is a small trial for patients with acute myelogenous leukemia (AML) who refuse transfusion with blood components and therefore cannot currently undergo induction chemotherapy, which depletes oxygen-carrying capacity. FDA, as previously reported, has indicated that this could be a pivotal trial, which means that Hemopure might seek a registration for this narrow, yet significant, indication before other applications. The protocol is being drafted by Biopure scientists and by outside experts in this field.

NMRC continues to be in discussion with the FDA regarding two trials under consideration, both of which would be for pre-hospital resuscitation of patients with severe traumatic hemorrhagic shock. Originally, NMRC sought approval for a study entitled "Restore Effective SUrvival in Shock" (R
'/>"/>

SOURCE Biopure Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Biopure Announces Private Equity Financing
2. Biopure Granted Additional 180 Day Compliance Period by NASDAQ
3. Biopure Announces MHRA Meeting Update
4. Biopure Announces 2008 Second Quarter Financial Results
5. Biopure Appoints Dechra Exclusive U.S. Distributor of Oxyglobin
6. Biopure Announces Date to Meet with UKs Medicines and Healthcare Products Agency
7. Biopure Operations Compliant With U.K. Manufacturing Guidelines
8. Biopure Appoints New Independent Auditor
9. Biopure Completes U.K. Regulatory Agency Inspection
10. Biopure Announces 2008 First Quarter Financial Results
11. Biopure Launches Updated Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Denville, NJ (PRWEB) January 22, 2015 ... shearing technologies such as the Bioruptor® and complete ... semi-automation system for chromatin immunoprecipitation, alleviating the need ... reagents and controls needed for ChIP of histones ...
(Date:1/22/2015)... , Jan. 22, 2015  Derma Sciences, Inc. ... company focused on advanced wound care, announces that ... tissues, have been added to the Premier, Inc. ... the opportunity for the AMNIOEXCEL® and AMNIOMATRIX® product ...
(Date:12/24/2014)... Dec. 24, 2014   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade hypothermic storage and cryopreservation ... for cells and tissues  ("BioLife" or the "Company"), today announced ... on May 4, 2015 (the "Annual Meeting"). Because ...
(Date:12/24/2014)... Bethesda, MD (PRWEB) December 23, 2014 ... law H.R. 83, the Omnibus and Continuing Resolution Appropriations ... hydrocephalus a condition eligible to receive funding through the ... Department of Defense (DoD). The Hydrocephalus Association (HA), working ...
Breaking Biology Technology:Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2
... Bio Corporation says its scientists have developed a ... ,Antibodies, naturally part of the immune system, are manufactured ... or research. Mirus' new technique, described in the February ... whose immune systems produce the antibodies that are harvested ...
... — Inacom Information Systems was awarded ... company's annual partner summit in San Diego, California. , ... campaign, which the company said drew 47 interested companies ... an implementation of wireless technology. , ,The campaign began ...
... Cyber Defense Agency, an information security consulting ... said it has been chosen to challenge eight student ... are increasing in complexity and sophistication, so it's essential ... the next generation of cyber defenders," said Sami Saydjari, ...
Cached Biology Technology:
(Date:12/19/2014)...   LaunchKey , the first decentralized mobile authentication and ... Things era, today announced the close of $3 million ... by Metamorphic Ventures with participation from ENIAC Ventures, Crosslink ... LaunchKey has raised $4 million to date, and will ...
(Date:12/17/2014)... Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) has ... Market 2015-2019" report to their offering. ... trend upcoming in this market is the increasing demand ... in recording of patient data for quick and correct ...
(Date:12/11/2014)... N.C. , Dec. 10, 2014  That blood pressure plays ... a while. Hypertension – the medical term for high blood ... early 1800s, and the inflatable cuff that,s used in measuring ... however, mean there,s nothing new about hypertension, its triggers and ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... of deaths in the United States every year. The disease ... supply blood to the heart muscle. This occurs as a ... to progressive buildup of fatty plaque near the surface of ... month in the SIAM Journal on Applied Mathematics , ...
... Dec. 9, 2013  Bruin Biometrics, LLC ("BBI") an ... has received ISO 13485:2003 and EN ISO 13485:2012 ... System with its notified body SGS. Receipt of ... in the design, development, manufacture, and distribution of ...
... As embryonic tissue develops, cells push and pull ... for the tissue to develop properly. Now scientists at ... these forces in three-dimensional (3D) tissues and living embryos. ... lead to new tools to diagnose cancer, hypertension, connective ...
Cached Biology News:Math models enhance current therapies for coronary heart disease 2Math models enhance current therapies for coronary heart disease 3Measuring life's tugs and nudges 2Measuring life's tugs and nudges 3
Mouse anti-IkBa/MAD-3 Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
Rabbit polyclonal to Oct2, prediluted ( Abpromise for all tested applications). entrezGeneID: 5452 SwissProtID: P09086...
Anti-Mouse Reticular Fibroblast, Purified (Clone ER-TR7) (rat IgG2a)...
Mouse monoclonal [2Q2147] to Aequorin ( Abpromise for all tested applications)....
Biology Products: